CelLBxHealth PLC CLBX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX0.85
- Day Range
- GBX0.87–0.95
- 52-Week Range
- GBX0.70–3.50
- Bid/Ask
- GBX0.85 / GBX0.95
- Shares Outstanding
- 1.14B
- Market Cap
- GBX1.08B
- Volume/Avg
- 3M / 2M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.61
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
CelLBxHealth PLC is engaged in the development and commercialisation of the Parsortix platform, with deployment in liquid biopsy - non-invasive cancer diagnostics. It operates in single segment of commercialisation of its Parsortix cell separation platform. It generates revenue from contracts with customers in the research-use market, with customers located across multiple geographic regions. Geographically it operates in UK, Europe, North America, and Rest of World with majority of revenue deriving from Europe and North America.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 114
- Website
- https://www.cellbxhealth.com
Valuation
|
Metric
|
CLBX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.61 |
Price/Sales | 2.61 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CLBX
|
|---|---|
Quick Ratio | 2.07 |
Current Ratio | 2.54 |
Interest Coverage | −68.41 |
Quick Ratio
CLBX
Profitability
|
Metric
|
CLBX
|
|---|---|
Return on Assets (Normalized) | −95.64% |
Return on Equity (Normalized) | −225.50% |
Return on Invested Capital (Normalized) | −122.76% |
Return on Assets
CLBX
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|!Cv^nqH$ | LOCK|$% | $245B | |||
| Danaher Corp
DHR
| LOCK|<^ZYmbl$ | LOCK|?js | $156B | |||
| Agilent Technologies Inc
A
| LOCK|zkc&fBb | LOCK|>> | $48B | |||
| IQVIA Holdings Inc
IQV
| LOCK|Yh!p&gg | LOCK|&?n$z | $43B | |||
| Waters Corp
WAT
| LOCK|XV?f%& | LOCK|#> | $42B | |||
| Illumina Inc
ILMN
| LOCK|gG&VNrg | LOCK|!Xhfk | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|>nQ>c@S | LOCK|FPJ | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|$HzVnv&^ | LOCK|@%fH | $31B | |||
| Quest Diagnostics Inc
DGX
| LOCK|>^%%^% | LOCK|??z#Q | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|D#<ZTG# | LOCK|>xlG! | $26B |
United States